Duloxetine for LBP
Part of paid clinical trials in The Bronx, New York.
- Sponsor
- Montefiore Medical Center
- Study ID
- NCT05851976
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Back Pain, Low
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 64 Years
- Healthy Volunteers
- Not accepted
Interventions
- Naproxen — DRUGNaproxen 500mg twice daily for 16 days
- Duloxetine — DRUGDuloxetine 60mg daily for 14 days
Study Details
This research study will help determine whether a medication called duloxetine can improve back pain. It is well documented that many participants who come to the ER with acute low back pain still have low back pain 3 months later. The investigator team will attempt to determine whether duloxetine can help prevent this.
Key Dates
- Start date
- Oct 4, 2023
- Status verified
- Dec 2025
- Primary completion
- May 31, 2027
- Completion
- May 31, 2027
Study Design
- Enrollment
- 120 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Naproxen + duloxetine
- Placebo Comparator: Naproxen + placebo
Primary Outcome Measure
Number of participants with moderate or severe Low Back Pain (LBP) [ Time Frame: 16 days, 42 days and 84 days after ED discharge ]
Central Contacts
- Benjamin Friedman, MD718-920-6626
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Montefiore Medical Center | The Bronx | New York | 10467 |
Find similar trials in The Bronx, NY
By research site
Related Studies
- AuriculoTherapy NeuroImagingRecruiting · Keith M Vogt · Pittsburgh, Pennsylvania
- Hormones, Outcomes, and Pain Pathways in Exercise StudyPHASE1 · Recruiting · University of Houston · Houston, Texas